Argiles, G., Margalef, N. M., Valladares-Ayerbes, M., de Prado, J. V., Grávalos, C., Alfonso, P. G., Santos, C., Tobeña, M., Sastre, J., Benavides, M., Cano, T., Loupakis, F., Garrote, M. R., Rivera, F., Goldberg, R., Falcone, A., Bennouna, J., Ciardiello, F., Tabernero, J., & Aranda, E. (n.d.). o-026Results of REARRANGE trial: A randomized phase 2 study comparing different dosing approaches for regorafenib (REG) during the first cycle of treatment in patients (pts) with metastatic colorectal cancer (mCRC). Annals of oncology, 30, . http://access.bl.uk/ark:/81055/vdc_100094627012.0x00002f